Importance: Anti-type VII collagen autoantibodies are often detectable in patients with bullous systemic lupus erythematosus (BSLE). However, the timing of their appearance preceding the onset of disease is unknown to date.

Observations: We report the case of a 50-year-old woman with a history of SLE who was seen with vesicles and bullae around her lips, trunk, axillae, arms, and thighs. Histologic analysis and immunofluorescence and immunoblot studies confirmed the diagnosis of BSLE. Immunoblotting and enzyme-linked immunosorbent assay studies of the patient's serum obtained 3 months before the onset of BSLE showed the presence of anti-type VII collagen autoantibodies. Levels of anti-type VII collagen IgG increased after bullous lesions appeared. Within 1 month after initiating dapsone therapy and increasing the dosage of prednisone, skin lesions promptly resolved. One year after the onset of BSLE, the anti-type VII collagen IgG decreased below levels observed before the inception of the bullous lesions.

Conclusions And Relevance: Anti-type VII collagen autoantibodies can precede the clinical appearance of BSLE. The subsequent increase and decrease in levels of circulating anti-type VII collagen autoantibodies, which mirrored skin disease activity, support a potential role in their initiation of disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874328PMC
http://dx.doi.org/10.1001/jamadermatol.2014.4409DOI Listing

Publication Analysis

Top Keywords

vii collagen
28
anti-type vii
24
collagen autoantibodies
20
bullous systemic
8
systemic lupus
8
lupus erythematosus
8
onset bsle
8
collagen igg
8
vii
7
collagen
7

Similar Publications

Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa.

Nat Commun

January 2025

National Institute of Health and Medical Research (INSERM) UMRS-976 HIPI, Paris Cité University, Saint-Louis Hospital, 75010, Paris, France.

Endotypes are characterized by the immunological, inflammatory, metabolic, and remodelling pathways that explain the mechanisms underlying the clinical presentation (phenotype) of a disease. Recessive dystrophic epidermolysis bullosa (RDEB) is a severe blistering disease caused by COL7A1 pathogenic variants. Although underscored by animal studies, the endotypes of human RDEB are poorly understood.

View Article and Find Full Text PDF

Effect of Adipose Stem Cells Injection on Type VII and VIII Collagen Expression of Wistar Rat's Gingiva.

J Contemp Dent Pract

September 2024

Department of Periodontics, Faculty of Dental Medicine, Airlangga University, Surabaya, Indonesia, Phone: +082146474590, e-mail:

Aims: This study investigated the effect of injection of adipose stem cells (ASCs) on the expression of type VII and VIII collagen in Wistar rat's gingiva. Adipose stem cells can modulate the immune system, angiogenesis, wound healing, and extracellular matrix (ECM) remodeling.

Materials And Methods: Ten Wistar rats aged three months were divided into two groups: the treatment group and the control group.

View Article and Find Full Text PDF

Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic disorder due to pathogenic variants in the COL7A1 gene. In this study we determined the association between different categories of COL7A1 variants and clinical disease severity in 236 RDEB patients in North America. Published reports or in-silico predictions were used to assess the impact of pathogenic variants in COL7A1 on type VII collagen (C7) protein function.

View Article and Find Full Text PDF

Red cell microparticles produced using high-pressure extrusion enhance both primary and secondary hemostasis.

Pharmacol Rep

January 2025

Department of Neurology, Peritz Scheinberg Cerebral Vascular Disease Research Laboratories, University of Miami Miller School of Medicine, 1600 NW 10th Ave RMSB #7046, Miami, FL, 33136, USA.

Background: Current therapies to treat excessive bleeding are associated with significant complications, which may outweigh their benefits. Red blood cell-derived microparticles (RMPs) are a promising hemostatic agent. Previous studies demonstrated that they reduce bleeding in animal models, correct coagulation defects in patient blood, and have an excellent safety profile.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!